Early feeding could help reduce liver dysfunction in critically ill patients
Changing the way that critically ill patients suffering from sepsis or multiple organ failure are fed could reduce liver dysfunction. A large study published today in the journal Critical Care recommends that clinicians should strictly control calorie intake, start artificial nutrition within 24 hours and regularly monitor liver function in patients at high risk.
Depression detection tool to transform treatment of cancer
A tool to detect depression in cancer patients launched by the University of Liverpool will vastly improve patients' ability to come to terms with their disease. more
Stem cells cultured from human bone marrow behave like those derived from brain tissue
Stem cells taken from adult human bone marrow have been manipulated by scientists at the Maxine Dunitz Neurosurgical Institute at Cedars-Sinai Medical Center to generate aggregates of cells called spheres that are similar to those derived from neural stem cells of the brain. more
Homicide Studies: Research is first to explore regional differences in US serial killings
Did you know that people living in the Western region of the United States are more likely to become victims of a serial killer than people living in the Northeast? The February issue of Homicide Studies, published by SAGE, is the first to explore research looking at the considerable interstate and regional differences in serial killer activity. more
Scientists discover a genetic risk factor for smoking-linked head and neck cancer
A simple blood test may be able to identify those most at risk for developing head and neck cancer as a result of smoking. This was the finding of a recent study by Prof. Zvi Livneh, Head of the Weizmann Institute's Biological Chemistry Department, Dr. Tamar Paz-Elizur of the same department, and their research team that worked in collaboration with Dr. Rami Ben-Yosef of Tel Aviv-Sourasky Medical Center, Prof. Laurence Freedman of Sheba Medical Center and Prof. Edna Schechtman of Ben-Gurion University of the Negev.
A recently licensed nicotine receptor stimulant triples the odds of stopping smoking
The new anti-smoking drug varenicline was first licensed for use in the UK on 5th December 2006. An early Cochrane Review' of its effectiveness shows that it can give a three-fold increase in the odds of a person quitting smoking. Varenicline is the first new anti-smoking drug in the last ten years, and only the third, after NRT and bupropion, to be licensed in the USA for smoking cessation. more
New evidence boosts the conclusion that some antidepressants can double a smokerís chance of quitting
The most recent Cochrane Review≤ concluded antidepressants bupropion (Zyban) and nortriptyline double a personís chances of giving up smoking and have few side-effects, but selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac) are not effective. more
© Vidyya. All rights reserved.